^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    LNC-003

    i
    Other names: LNC-003
    Associations
    News
    Trials
    Company:
    Rebus
    Drug class:
    Adenosine A2A receptor antagonist, Adenosine A2B receptor antagonist
    Related drugs:
    Associations
    News
    Trials